Medline Articles

Crigger, NJ. Pharmaceutical promotions and conflict of interest in nurse practitioner's decision making: the undiscovered country. Journal of the American Academy of Nurse Practitioners. 17(6): 207-12, 2005.

Wall, LL & Brown, D. The high cost of a free lunch. Obstetrics & Gynecology. 110(1): 169-73, 2007.

Nelson, R. When ads trump evidence: is direct-to-consumer advertising leading practice? American Journal of Nursing. 107(10): 25-6, 2007.

Lohiya, S. & Lohiya, S. The suboptimal legibility of prescribing information in pharmaceutical advertisements. Journal of the American Board of Family Medicine: JABFM. 20(3): 314-5, 2007.

Singer, E. Aggressive drug marketing tactics trigger backlash. Nature Medicine. 13(4): 393, 2007.

Wazana, A.  Physicians and the pharmaceutical industry: Is a gift ever just a gift? JAMA, vol. 283(3), January 19, 2000, 373-380.

Steinbrook, R.  For sale: Physicians’ prescribing data. New Eng Jrn of Medicine. Vol 354 (26), June 29, 2006, 2745-2747.

Watkins, C., Moore, L., Harvey, I., et al.  Characteristics of general practitioners who frequently see drug industry representatives: national cross sectional study. BMJ, Vo. 326, May 31, 2003, 1178-1179.

Stokamer, CL.  Pharmaceutical gift giving: Analysis of an ethical dilemma. J Nursing Administration, Vol 33(1), January 2003, 48-51.

Blumenthal, D.  Doctors and drug companies. New Eng Jrn of Medicine. Vol 351 (18), October 28, 2004, 1885-1890.

Averett, W. & Rising, J.  The Pharmaceutical Industry: Profits before people. American Medical Student Association.

Newland, J. Direct-to-consumer ads impact practice. Nurse Practitioner: The American Journal of Primary Health Care, 32(8): 5, 2007.

Pearson, LJ. Editor's memo. Can prescriber profiling happen to you? Nurse Practitioner: American Journal of Primary Health Care. 28(12): 8, 2003.

Brett, AS. Cheap trinkets, effective marketing: small gifts from pharmaceutical companies to physicians. American Journal of Bioethics. 3(3): 52-4, 2003.

Morin, K. & Morse, LJ. The ethics of pharmaceutical industry gift-giving: the role of a professional association. American Journal of Bioethics. 3(3): 54-5, 2003.

Brody, H. Pens and other pharmaceutical industry gifts. American Journal of Bioethics. 3(3):58-60, 2003.

Strong, C. Lunch with lilly: who pays? American Journal of Bioethics. 3(3): 62-3, 2003.

Donohue, JM, Cevasco, M, Rosenthal, MB.  A decade of direct-to-consumer advertising of prescription drugs.  N Engl J Med.  357 (7): 673-81, 2007 Aug 16.

Mastin, T, Andsager JL, Choi J, Lee K.  Health disparities and direct-to-consumer prescritption drug advertising:  a content analysis of targeted magazine genres.  Health Commun. 2291): 49-58, 2007.

Lewis, PR.  Advertising, sponsorship, and conflict of interest.  J Family Practice.  56(5):344, May 2007.

Fugh-Berman A., Ahari, S.  Following the script:  how drug reps make friends and influence doctors.  Public Library of Science Med., 4(4):e150, April 2007.

Steinman, MA, Harper, GM, Chren, MM, Landefeld, CS, Bero, LA. Characteristics and impact of drug detailing for gabapentin.  Public Library of Science Med, 4(4):e134, April 2007.

Avorn, J.  The marketplace can't give us the drug safety data we need.  MedGenMed., 9(1):29, 2007.

Morgan, MA, Dana, J., Loewenstein, G, Zinberg, S., Schulkin, J.  Interactions of doctors with the pharmaceutical industry.  J Med Ethics, 32(10):559-63, October 2006.

Chimonas, S., Brennan, TA, Rothman, DJ.  Physicians and drug representatives: exploring the dynamics of the relationship.  Journal of Gen Intern Medicine.  22(2): 184-90, February 2007.

Greene, JA.  Pharmaceutical marketing research and the prescribing physician.  Annals of Intern Med., 146(10):742-8, May 15, 2007.

Shuchman, M.  Drug risks and free speech: can Congress ban consumer drug ads?  N Engl Journ Med., 356(22):2236-9, May 31, 2007.

Campbell EG, Gruen, RL, Mountford, J., Miller, LG, Cleary, PD, Blumenthal, D.  A national study of physician-industry relationships.  N Engl Journ Med., 356(17):1742-50, Apr 26, 2007.

Johnston, SC, Hauser, SL.  Marketing and drug costs: who is laughing and crying?  Annals of Neurology, 61(2):11A-12A, February 2007.

Triggle, DJ.  Treating desires not diseases: a pill for every ill and an ill for every pill?  Drug Discovery Today, 12(3-4):161-6, February 2007.

Moffatt, B, Elliott, C.  Ghost marketing: pharmaceutical companies and ghostwritten articles.  Perspectives in Biology & Medicine. 50(1):18-31, 2007.

Bradford, WD, Kelit, AN, Nietert, PJ, Steyer, T., McIlwain, T., Ornstein, S.  How direct-to-consumer television advertising for osteoarthritis drugs affects physicians' prescribing behavior.  Health Affairs. 25(5):1371-7, Sep-Oct 2006.

Burton, B.  Roche fined over "extravagant" meals for doctors.  BMJ. 334(7590):384, Feb 24, 2007.

An, S. Attitude toward direct-to-consumer advertising and drug inquiry attention: the moderating role of perceived knowledge. Journal of Health Communication. 12(6):567-80, 2007.

Davis, JJ, Cross, E, & Crowley, J. Pharmaceutical websites and the communication of risk information. Journal of Health Communication. 12(1): 29-39, 2007.

Dear, JW & Webb, DJ. Disease mongering--a challenge for everyone involved in healthcare. British Journal of Clinical Pharmacology. 64(2): 122-4, 2007.

Hack, EI. Pharmaceutical global marketing practices: increased scrutiny ahead? Food & Drug Law Journal. 62(2):343-8, 2007.

Kallen, A, Woloshin, S, Shu, J, Juhl, E, & Schwartz, L. Direct-to-consumer advertisements for HIV antiretroviral medications: a progress report. Health Affairs. 26(5): 1392-8, 2007.

Kessenich, CR & Westbrook, MH. Search and research. Pharmaceutical companies and the prescriptive practices of nurse practitioners. Journal of the American Academy of Nurse Practitioners. 11(12): 533-8, 1999.

Ljungberg, C, Lindblad, AK, & Tully, MP. Hospital doctors' views of factors influencing their prescribing.  Journal of Evaluation in Clinical Practice. 13(5): 765-71, 2007.

Lorence, D & Churchill, R. A study of the web as DTC marketing agent. Journal of Medical Systems. 31(6): 551-6, 2007.

Macias, T, Pashputi, K, & Lewis, LS. A wonderful life or diarrhea and dry mouth? Policy issues of direct-to-consumer drug advertising on television. Health Communication. 22(3): 241-52, 2007.

Quan, SF. Doctor, do you have a minute? The dilemma posed by physician interaction with the pharmaceutical industry. Journal of Clinical Sleep Medicine. 3(4):345-6, 2007.

Schneiderman, LJ. The media and the medical market. Cambridge Quarterly of Healthcare Ethics. 16(4):420-4, 439-42, 2007. 

Schwartz, LM, Woloshin, S, & Welch, HG. The drug facts box: providing consumers with simple tabular data on drug benefit and harm. Medical Decision Making. 27(5):655-62, 2007.

Shah, MB, Bentley, Jp, & McCaffrey, DJ. Evaluations of care by adults following a denial of an advertisement-related prescription drug request: the role of expectations, symptom severity, and physician communication style. Social Science & Medicine. 62(4): 888-99, 2006.

Spurling, G & Kyle, G. Is your sample cupboard relevant to your practice? Australian Family Physician. 36(3): 187-9, 192, 2007.

Steinman, MA & Baron, RB. Is continuing medication education a drug-promotion tool? Yes [see comment]. Canadian Family Physician. 53(10):1650-7.